InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-31.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Lamattina John l, Director. Officer active across 2 companies, notably Immunome Inc.. Cumulatively, 12 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €379k. History available since 24 May 2021. The latest transaction was filed on 6 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lamattina John l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
2,161 shares@ US$114.1525.2% of flowCommon StockSEC:0002001011-26-000036:0
2,161 shares@ US$200.7644.3% of flowCommon StockSEC:0002001011-26-000036:1
2,145 shares@ US$66.1312.7% of flowCommon StockSEC:0002001011-25-000097:0
1,209 shares0Common StockSEC:0002001011-25-000044:0
2,406 shares@ US$52.3030.4% of flowCommon StockSEC:0002001011-24-000093:0
1,252 shares0Common StockSEC:0002001011-24-000059:0
1,142 shares0Common StockSEC:0000886163-23-000042:0
15,125 shares@ US$4.0084.5% of flowCommon StockSEC:0001104659-23-004007:0
1,004 shares0Common StockSEC:0000886163-22-000079:0
4,835 shares@ US$32.3014.2% of flowCommon StockSEC:0000886163-21-000136:0
630 shares0Common StockSEC:0000886163-21-000089:0
338 shares@ US$18.448.4% of flowCommon StockSEC:0001104659-21-072617:0
Canonical exit: 22 Aug 2021 (T+90)
12 of 12 declarations
About Lamattina John l
LAMATTINA JOHN L is Administrateur of Ligand Pharmaceuticals INC and Immunome Inc. He has 12 filings in total, and across the sampled recent filings they span from 2021-05-26 to 2026-03-31, with EUR 5103 in buys and EUR 373742 in sales, and the modal transaction nature is Attribution.
